All Clinical Applications Of Gene Sequencing Halted By China FDA’s New Regulations
This article was originally published in PharmAsia News
Executive Summary
China FDA and the National Health and Family Planning Commission (NHFPC) announced jointly that medical institutes should not develop clinical applications of gene sequencing or should stop development immediately before the relevant standards, management, and regulations are issued.